About Us
For Organizations
For Individuals
For Investors
- News & Events
- Press Releases
- Filings
- Stock Info
- Governance
- Alerts
- FAQs
Resources
Shop

1.4%

improvement

in eA1c in users with T2D over 12 months

Decrease in Estimated A1C for People in High-risk Group Over a Full Year of Users Monitoring with a Digital Diabetes Management System
AADE 2018

38%

of users reduced their hypertension

by one stage over 3 months

Users with Type-2 Diabetes Using a Digital Platform Experienced Sustained Improvements in Blood Glucose Levels
ADA 2020 860-P

14%

reduction in average blood glucose in users

with T2D over 12 months

Continuous Reduction of Blood Glucose Average during One Year of Glucose Monitoring Using a Digital Monitoring System in a High-Risk Population
ADA 2018 78-LB

10%

increase in in-range glucose levels

linked to app engagement in users with T2D over 6 months

T2D Users of a Digital Diabetes Management System Experience an Increase of in-range Glucose Levels Linked to App Engagement
ADA 2019 912-P

58%

decrease

in hyperglycemic events in users with T2D over 12 months

Decrease in High Readings and Severe Hyperglycemic Events for People with T2D over the Full Year of 2017 in Users Monitoring with a Digital Diabetes Management System
ADA 2018 77-LB

13%

improvement

in blood glucose average in members 65+ with T2D over 6 months

The Effect of a Digital Therapeutic Platform on Glycemic Control in Adults above Age 65 with Type 2 Diabetes
DTS 2020

26%

reduction in average ratio

of high blood glucose events in users with T2D over 12 months

Users with Type-2 Diabetes Using a Digital Platform Experienced Sustained Improvements in Blood Glucose Levels
ADA 2020 860-P

39%

increase

of % in-range measurements per total measurements versus baseline over 3 months

Impact of Digital Intervention on In-range Glucose Levels in Users with Diabetes
AADE 2019

Contact Us

Follow Us

Supported Devices

Dario Support Toll-Free: 833-914-3796

© 2022 DarioHealth Corp. View our Privacy Policy or Terms and Conditions

DarioHealth is a publicly traded company (Nasdaq: DRIO).

Your cart (0)

You have no products in the cart

Continue shopping